6TH OCTOBER 2022 | LONDON
This World Lung Day, Verona Pharma is raising awareness of the debilitating … Continue reading “A Q&A by Verona Pharma ahead of World Lung Cancer Day”
The award highlights significant company growth and advancement in the field of RNA modifying enzymes (RME) as STORM aims to become the global leader in the field of RME.
Inbiomotion, a Barcelona based company developing a unique single-gene-based biomarker for the … Continue reading “Use of Inbiomotion’s MAFTEST® leads to huge reduction in breast cancer mortality”
Dr Kathleen Rickard, MD, Chief Medical Officer of Verona Pharma, highlights the … Continue reading “The burden of COPD and potential impact of novel therapeutics by Verona Pharma”
In Vivo ‘Rising Leader’ Thijs Cohen Tervaert, Junior Partner at INKEF shared his thoughts with In Vivo’s Jo Shorthouse on the European funding landscape, the importance of software, and sustainable investments, and his investment priorities.
HealthTech For Care’s HealthTech Innovation Days (HTID#4) returns on 12-14 October in Paris and virtually. This year, Optimum is a proud supporter of HTID#4 investor relations.
Optimum Strategic Communications is delighted to announce that ISA Pharmaceutical’s Chief Scientific … Continue reading “ISA Pharmaceuticals’ Chief Scientific Officer Prof. Dr. Melief Awarded Fellowship at the Society for Immunotherapy of Cancer”
In Vivo ‘Rising Leader’ Dr. Mårten Steen, Managing Partner at HealthCap speaks with Ayisha Sharma on growing a successful precision medicine businesses from the ground up and the importance of high-energy leadership.
One Nucleus’ ON Helix provided insightful and thought-provoking discussions, with a key theme being collaboration, facilitating all aspects of bio innovation.
Now in its fifth year, the LSX Nordic Congress continues to help Nordic-based companies access local and international capital and strategic partners.
Novo Ventures, the ventures arm of Novo Holdings, has published its review of the last 18 months, a period that saw significant progress across all areas of the business.
Optimum Strategic Communications is pleased to support Versameb during World Continence Week, … Continue reading “Highlighting the need for a therapeutic solution in Stress Urinary Incontinence during World Continence Week”
Find out what sets Ariceum Therapetutics apart within the radiopharmaceutical arena in this insightful interview with its CEO Manfred Rüdiger and Tyler Patchen of Endpoint News
Synklino, the emerging biotech company developing breakthrough drugs for the treatment of … Continue reading “Synklino’s Breakthrough Approach to Eliminate Transplant Related CMV”
Optimum supports One Nucleus’ flagship conference, ON Helix, which brings the network … Continue reading “ON Helix Digital Conference 2022”
Novo Ventures senior partner, Naveed Siddiqi, discussed the opportunity in a slumbering IPO market to raise larger funding rounds, in an interview with Unquote.
For more information about Optimum Strategic Communications, please get in touch
We'd love to hear from you...GET IN TOUCH